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Lymphoproliferative Disease in Mice Infected
with Murine Gammaherpesvirus 68
N. P. Sunil-Chandra, J. Arno, J. Fazakerley,
and A. A. Nash
From the Department ofPathology, University of
Cambridge, Cambridge, United Kingdom
Murinegammaherpesvirus is a naturalpathogen
ofwild rodents. In the laboratory it establishes an
infection of epithelial ceUs andpersists in B lym-
phocytes in a latentform. Inbred mice chronically
infected with the virus develop a lymphoprolif-
erative disease (LPD) similar to that seen in pa-
tients infected with Epstein-Barr virus. The fre-
quency ofLPD over aperiod of3years was 9% of
all infected animals, with 50% ofthese displaying
highgrade lymphomas. The incidence ofLPD was
greatly increased when infected mice were
treated with cyclosporin A. The majority of mice
used in the experiments were BALB/c, although
lymphomas were detected in mice on othergenetic
backgrounds, ie, CBA and BlOBr. Lymphomas
were associated with both lymphoid and nonlym-
phoid tissues (liver, lung, and kidney). In all
cases of lymphomas studied thusfar, there was
a mixed B ceU (B220+ve) and T cell (CD3+ve)
phenotype. TheB cells were light chain restricted,
indicative ofa clonal origin. Variable numbers of
virus genome-positive cells were detected by in
situ hybridization in and around the lymphomas.
In contrast, no lytic antigen-positive ceUs were de-
tected, indicating that genome-positive cells were
either latently infected or undergoing an abortive
infection. These observations suggest that murine
gammaherpesvirus-infected mice may be an im-
portant model to study the pathogenesis ofLPD
associated with other gammaherpesviruses,
such as Epstein-Barr virus. (AmJ Pathol 1994,
145:818-826)
The gammaherpesviruses are divided into two sub-
groups: gamma 1 viruses represented by Epstein-
Barr virus (EBV) and gamma 2 viruses typified by her-
pesvirus saimiri (HVS) and other related viruses of
New World monkeys. These viruses are associated
with lymphoproliferative disease (LPD) in the infected
host and can efficiently transform lymphocytes in-
fected in vitro. EBV, the causative agent of infectious
mononucleosis, is also associated with Burkitt's lym-
phoma, nasopharyngeal carcinoma, and a variety of
LPDs observed in immunocompromised individuals
such as those with AIDS and in posttransplant pa-
tients. 12 In contrast, HVS causes an inapparent in-
fection in the natural host but induces polyclonal lym-
phoid neoplasia in related species.3
Animal models have contributed greatly to our un-
derstanding of alphaherpesvirus and betaherpesvi-
rus infections. Models of EBV infection have proven to
be more difficult to establish, although some forms of
LPD have been induced in primates and severe com-
bined immunodeficiency (SCID) mice.1-7 More re-
cently, a mouse gammaherpesvirus has been de-
scribed that is a natural pathogen of wild rodents, ie,
voles and mice.89 Infection of laboratory mice with
this virus results in replication in alveolar epithelial
cells and the establishment of a persistent/latent in-
fection in B lymphocytes.10'11 Furthermore, this virus
will also infect myeloma cells (B cell lineage) in vitro,
where a state of latency can be produced in which the
viral genome exists in an episomal form.12
In mice chronically infected with MHV-68, we have
identified a variety of pathological changes with a
high incidence of LPD. The latter showed a range of
histological appearances and affected both lymph
nodes and spleen, as well as extranodal sites. In the
case of lymphomas the magnitude of the disease
ranged from low grade to high grade lymphomas, as-
sociated with both lymphoid and nonlymphoid tissue.
In this report we describe our findings on the nature
of the tumors produced and the association of these
with the virus.
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Materials and Methods
Mice
Female BALB/c (H-2d), C57BL/10 (H-2b), and CBA
(H-2k) mice were obtained from Bantin and Kingman
(Hull, UK) or Olac Ltd. (Bichester, UK) and were in-
fected at 3 to 4 weeks of age. Animals were main-
tained in three different animal units during the course
of these experiments. Mouse hepatitis virus and Sen-
dai virus were identified in two of the units.
Virus
MHV-68 was originally obtained from Professor D.
Blaskovic8 and the clone G2.4 was isolated.9 13 Virus
was grown in BHK cells at a low multiplicity of infection
(0.1 pfu/cell) and working stocks stored at -70 C.10
Intranasal and Intravenous Infection
of Mice
Mice were inoculated intranasally or intravenously
with 4 x 105 pfu of MHV-68. Approximately 40 pl of
virus was administered intranasally to mice under
light anesthesia. For intravenous inoculation, 0.1 ml of
the virus dilution was injected into the tail vein. Mice
were caged in groups of four. No evidence of hori-
zontal transmission of this virus has so far been de-
tected between groups of infected and uninfected
mice (unpublished observations).
Cyclosporin A (CsA) Treatment of
MHV-68-Infected Mice
A group of infected animals were treated with CsA (a
gift from Dr. D. White, Department of Surgery, Adden-
brookes Hospital, Cambridge, UK). Infected mice
were injected intraperitoneally with 1 mg CsA in 0.1 ml
of olive oil (equivalent to 50mg/kg) on 3,7,14,21, and
28 days after the first injection. Another group of in-
fected animals received olive oil only.
Histopathological and
Immunohistochemical Studies
Various tissues (heart, kidney, lung, liver, spleen, thy-
mus, mesenteric lymph nodes, pancreas, uterus,
ovary, and adrenal gland) were removed from mice
with clinical evidence of lymphomas and latently in-
fected mice with no clinical signs of disease at various
times after infection and immediately fixed in 10%
buffered formal saline. Organs from uninfected mice
acted as negative controls. Tissues were paraffin em-
bedded and 5-p-thick sections were stained with he-
matoxylin and eosin (H&E). In some experiments tis-
sues were removed then snap-frozen and prepared
for cryostat sections. Indirect immunoperoxidase an-
tibody labeling was used to detect virus antigen, CD3
(rat IgG2a, clone KT3; a gift from Dr. K. Tominari, Clini-
cal Research Centre, Harrow, UK) and B220 (rat
IgG2a, clone R36B2; Pharmingen, San Diego, CA),
as described by Sunil-Chandra et al.10 Briefly, par-
affin processed tissue sections were treated with
0.1% trypsin for 5 minutes to avoid problems asso-
ciated with overfixation of tissue specimens in forma-
lin. Nonspecific binding of antibodies was minimized
by the use of Tris-buffered saline for diluents and rins-
ing and by addition of a blocking step, which included
5% normal goat serum and 10% bovine serum albu-
min in the case of viral antigen or 5% normal rabbit
serum in the case of CD3 or B220 surface antigens.
Endogenous peroxidase activity was minimized by
immersing the slides in a solution of 0.75% hydrogen
peroxide in methanol for paraffin sections or 0.3% hy-
drogen peroxide diluted in Tris-buffered saline for
cryostat sections for 30 minutes. After this period all
paraffin sections were trypsin treated for 5 minutes.
Immunoperoxidase staining with an avidin/biotin de-
tection system using either goat anti-rabbit IgG
[heavy and light] chain biotinylated antibody for viral
antigens or rabbit anti-rat IgG [heavy and light] chain
biotinylated antibody for mouse surface antigens)
was performed using the Vectastain ABC kit (Vector
Laboratories, Bretton, Peterborough, UK).
Direct immunoperoxidase antibody labeling was
used to detect K- and A-chains using clonotyping sys-
tem 11 kit (SeraLab, Crawley Down, Sussex, UK). This
included goat anti-mouse K and A antibodies labeled
with horseradish peroxidase. DAB was used as the
substrate for direct and indirect immunostaining.
In Situ Hybridization
Tissue sections were prepared for in situ hybridiza-
tion, as described previously.10 Briefly, this involved
treating tissue sections with proteinase K, followed by
prehybridization (1 hour at 37 C) and then hybridiza-
tion with a 1.2-kb DNA probe (boiled for 5 minutes and
rapidly chilled on ice before adding to the hybridiza-
tion solution). To achieve a higher sensitivity, the
1.2-kb terminal repeat fragment of MHV-68 ge-
nome9,13 was used for preparation of 35S-labeled
DNA probes by random hexanucleotide priming. The
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pUC13 plasmid DNA-negative control probe and tis-
sue sections obtained from spleen, kidney, liver, lung,
heart, and mesenteric lymph node of an uninfected
mouse were also included to confirm the specificity of
hybridization. Immediately after addition of probe the
tissue sections were heated to 80 C for 10 minutes.
Hybridization was for 18 hours at 37 C. Sections were
then washed twice for 15 minutes with 2x standard
saline citrate (SSC) at room temperature, twice for 15
minutes with 0.1x SSC at room temperature, and
once for 10 minutes with 0.1 x SSC preheated to 60
C and kept at 37 C followed by a 15-minute wash with
2x SSC at 60 C. The sections were then dehydrated
via a series of graded alcohols, air-dried dipped in
photographic emulsion (prepared in a dark room by
adding 20 ml of Amersham LM-1 emulsion to 20 ml of
0.66 M ammonium acetate at 42 C), allowed to dry at
room temperature in a light-tight box for 2 hours, and
autoradiographed for 1 to 4 weeks at 4 C. Slides were
developed, fixed, counterstained with H&E, dehy-
drated, and mounted in DePeX.
Results
Pathological Changes in Mice Latently
Infected with MHV-68
The long-term pathological effects of MHV-68 infec-
tion were studied in 220 mice obtained from three
different animal units (see Materials and Methods).
These included 18 BALB/c mice infected intrave-
nously and 162 BALB/c, 20 C57BL/10, 10 B 1 OBr, and
10 CBA mice infected intranasally. The animals were
examined for the development of any clinical features
over a period of 3 years after recovery from the pri-
mary infection. Twenty-five of 220 (11%) mice be-
came clinically sick starting at varying times from 165
to 825 days postinfection (Table 1). These mice and
a group of clinically normal mice (15 of 220) were
killed during this postinfection period and various tis-
sues examined for gross pathological and his-
topathological changes. In more than 300 uninfected
BALB/c mice monitored under similar animal housing
conditions for similar time periods, no evidence of
clinical LPD or lymphomas were observed.
Clinical and Gross Pathological Features
Sick mice showed either moderate to massive en-
largement of the abdomen with abnormal gait or
weakness and emaciation. Animals with distended
abdomens usually had nodular splenomegaly, nodu-
lar hepatomegaly, or enlarged kidneys and in addition
some animals had lymphoid tumors of the mesenteric
lymph nodes, pancreas, ovary, or intestine (Figure 1).
In some animals, however, the abdominal distension
was caused by massive hemorrhagic uterine cysts.
Table 1. Pathological Features ofMHV-68-Infected Mice During a Long-Term Latent Infection
Mouse Days PI Strain/Route* Histopathological Features
1 165 BALB/c, i.n. Mild LPD in lung and CBP
2t 170 BALB/c, i.n. Mild LPD in lung and MLN
3 286 BALB/c, i.n. Mild LPD in lung and AT
4 290 BALB/c, i.n. AT and HEP in S
5 350 C57BI, i.n. Adenocarcinoma in the lung
6 376 BALB/c, i.n. Mild LPD in lung, K, CBP, and HEP in L
7 400 BALB/c, i.n. Uterine cyst
8 540 BALB/c, i.n. Mild LPD in K and carcinoma in 0
9 540 BALB/c, i.v. HGL in SP, L, K, lung, and MLN
10 635 B10Br, i.n. Focal nodular hyperplasia in L
11 665 CBA, i.n. Sarcoma of muscle
12 715 BALB/c, i.n. HGL in S, K, MLN, L, lung, and MGC
13 725 BALB/c, i.n. Mild LPD in K, L, lung, AT, and uterine cyst
14 725 C57BI, i.n. Mild LPD in lung, A, and HEP in L
15 725 BALB/c, i.n. HGL in MLN and P
16 725 BALB/c, i.n. HGL in S, K, L, and lung
17 725 C57BI, i.n. HGL in MLN and S
18 740 BALB/c, i.n. Mild LPD in K, lung, and INT
19 740 BALB/c, i.n. Mild LPD in lung, tumor in 0
20 767 BALB/c, i.n. Nodular LGL in S, lung, L, and K
21 790 BALB/c, i.n. Mild LPD in lung, L, K, AT, and HEP in S
22 810 C57BI, i.n. HGL in S, L, MLN, 0, K, A, and lung
23 810 CBA, i.n. HGL in S and L
24 824 BALB/c, i.n. LGL in K, lung, L, and uterine cyst
25 824 BALB/c, i.n. Mild LPD in lung, CBP, and uterine cyst
26 834 BALB/c, i.n. MGC
PI, postinfection; i.n., intranasal infection; i.v., intravenous administration; HGL, high grade lymphoma; LGL, low grade lymphoma; LPD,
lymphoproliferative disease; CBP, chronic bronchopneumonia; HEP, hemopoiesis; AT, atrial thrombosis; MGC, mammary gland carcinoma; S,
spleen, K, Kidney; MLN, mesenteric lymph node; L, liver; A, adrenal gland; 0, ovary; P, pancreas; INT, intestine.
* Mice were infected with 4 x 105 pfu virus except no. 7 which received 2 x 104 pfu.
t All mice except no. 2 were clinically sick.
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Figure 1. Gross pathologicalfeatures oflymphomas detected in BALB/c mice infected with murinegammaherpesvirus. A: An intra-abdominal lym-
phoma within the mesentery of mouse no. 15 at 725 days postinfection (indicated by an arrow). B: Splenomegaly in mouse no. 16 (at 725 days
postinfection) as a result of extensive splenic involvement by abnormal lymphoid cell masses that appear as yellowish-white nodular areas (indi-
cated by an arrow).
Animals with weakness and emaciation had consoli-
dation of the lung or enlarged hearts with lesions in
the atrium (Table 1).
Histopathological Changes
Among the 25 sick mice, 20 (9% of total) had devel-
oped lymphoproliferative disorders. In nine of these,
the disease was judged to be high grade lymphoma
most resembling centroblastic/centrocytic or plasma-
blastic non-Hodgkin's lymphomas seen in humans.
There was cellular pleomorphism and a high mitotic
rate. In some animals, abnormal plasma cells and oc-
casional cells resembling Reed-Sternberg cells in ap-
pearance were observed in the spleen (data not
shown). Spleen, mesenteric lymph nodes, liver, lung,
and kidney were the organs mainly affected (Figure 2,
A-C). In the spleen the normal lymphoid tissue was
replaced by nodular masses of lymphoma. In the
lung, lymphomatous tissue was distributed around
both bronchi and blood vessels; in the liver primarily
within portal tracts and in the kidney, deposits were
particularly peripelvic or subcapsular (Figures 2 and
4). In some cases, replacement of tissue parenchyma
was extensive.
When the histological appearance was that of a
milder lymphoproliferative disorder, a similar distribu-
tion to that described above was found, the lesions
being most obvious in lung, liver, and kidney. It may
be postulated that the lesser lymphoproliferative state
might constitute the basis from which the high grade
lymphomas would arise.
In 1 of 15 (mouse no. 2) latently infected but ap-
parently normal mice that were examined, there was
mesenteric node enlargement and consolidation of
the lungs characterized by histological appearance
of mild LPD.
Not all the clinically sick mice had LPD. Four had
a form of bronchopneumonia and six had lesions in
the heart. The former had purulent exudate within
bronchi that were surrounded by dense plasma cell
infiltration. Sometimes it was believed that mild LPD
A B
...m..
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Figure 2. Anatomical distribution of lymphomas in various organs of affected mice. A: H & E-stained tissue sections of spleen, lung, kidney, and
liver of mouse no. 16 shown in (B) that are infiltrated histologically by a high grade lymphoma (indicated by arrows) (magnification X 4). B: H&
E-stained section of the mesentenic lymph node shown in (A) of mouse no. 15 (magnification X 4). C: H & E-stained sections ofspleen and kidneys
of mouse no. 9. Arrows indicate massive lymphoid cell masses that occupy extensive areas of the spleen (magnification x 4). D: Autoradiographic
film images ofan adjacent tissue section taken from spleen and kidney shown in (C) of mouse no. 9 hybridized with a -35S-labeled MHV-68 DNA
(1.2-kb termninial repeatfragment) probe (magnification x 4). In situ hybridization shows the distribution of viral DNA in the spleen surrounding
lymphoid inasses ( inidicated by arrous). In the kidney signal is preferentially localized to central collecting area. In situ hybridization using nega-
tive conttrol -'S-labeled probe (pUC 13 plasmid DNA) in the adjacent sections showed no positivity (data not shown).
might also be present but it was impossible to be cer-
tain against the background of severe chronic inflam-
mation. The abnormality affecting the heart in some
cases was thrombosis in a dilated atrium, a finding
that would argue for some cardiac dysrhythmia be-
fore death. Six of 220 mice showed evidence of in-
crease in extramedullary hemopoiesis, suggesting
that there was bone marrow impairment (Table 1). Fur-
thermore, 6 of 220 animals had uterine abnormalities.
These consisted of endometrial hyperplasia and cys-
tic enlargement of the uterus filled by blood-stained
fluid. The occurrence of other pathological lesions
such as mammary gland carcinoma (2 of 220), ad-
enocarcinoma of the lung (1 of 220), focal nodular
hepatic hyperplasia (1 of 220), and a sarcoma arising
in skeletal muscle (1 of 220) were also observed.
Phenotype and Clonality of Lymphomas
A group of 30 MHV-68-infected mice were treated with
CsA, as described in Materials and Methods. The
CsA-treated and untreated group of animals were
then monitored for the development of clinical signs.
Over a period of 12 months, 60% of CsA-treated and
20% of untreated mice developed LPD affecting both
lymphoid and nonlymphoid tissue. A series of lym-
phoid tumors from the infected mice were analyzed
for the membrane phenotype of lymphocytes by im-
munoperoxidase staining of cryostat sections. Of
seven mice investigated with high grade lymphomas,
all showed a mixed T (CD3 positive) and B (B220
positive) cell phenotype, with CD4 T cells as the major
T cell subset. In all cases, the B cells showed light
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chain restriction: five with K-chain and two with
A-chain (Figure 3). In two cases the light chain re-
striction was associated with plasma cells. This sug-
gests a clonal derivation of B cells in these tumor-
bearing animals.
Detection and Distribution of Viral
DNA-Positive Cells in Organs Affected
with Lymphomas
In situ hybridization was used to detect viral DNA on
tissue sections of the mice presented in Table 1. An
increased number of positive cells were observed in
organs with mild LPD or high grade lymphomas when
compared with spleen sections from latently infected
normal mice10 or mice with other pathological (non-
LPD) conditions.
Mouse no. 9 developed a massively enlarged ab-
domen at 540 days postinfection. Pathological exami-
nation demonstrated dramatic nodular hepato-
splenomegaly and enlarged kidneys and mesenteric
lymph nodes as a result of lymphoma. Initially, in situ
hybridization was performed on tissue sections with
and without heating to 800 C to detect viral DNA and
RNA, respectively. Hybridization signal was apparent
in the spleen and kidney only in the treated sections,
suggesting that DNA is present in these cells but RNA
transcripts were absent or below the level of detection
(Figure 2, D).
In situ hybridization on several sections of spleen
and kidney obtained from mouse no. 9 repeatedly
showed virus genome-positive cells associated with
lymphomas (Figure 4, a and d). No virus antigen was
detected in adjacent sections of these organs by im-
munoperoxidase labeling (Figure 4, b and e). In the
same experiment, virus antigen could be detected in
lung tissue obtained from an acutely infected animal.
This observation strongly suggests that the positive
signal observed in association with the lymphoma is
due either to the presence of latent virus or an abortive
virus infection.
Studies on the tissues taken from other affected
animals showed DNA-positive cells in all the lympho-
Figure 3. Membrane phenotype of lymphocytesfrom a spleen with high grade lymphomas. Immunoperoxidase staining of cryostat sections for: (A)
B220, (B) CD3, (C) K-chain, and (D) light chain (magnification x500).
Figure 4. MHV-68 genome-positive cells associated with lymphomas in various organs as determined by in situ hybridization. a: A large number of
lymphoid cells positive for MHV-68 DNA (indicated by arrows) are surrounding Iymphomas in the spleen of mouse no. 9 (magnification X 125).
Insert shows a magnified view ofgenome-positive spleen cell ( magnification X 1250). b: Virus antigen was absentfrom the spleen where viral DNA-
positive cells were observed in (a), as determined by immunoperoxidase staining of adjacent tissue sections using hvperimmune rabbit polyclonal
sera (magnificatiotn X 250). c: Vinrs genome-positive cells in the lung of a mouse no. 14 with a high grade lymphoma. Massive lymphoid cell ac-
ciumuz(lations are seen in peribronchiolar and perivascular areas (indicated by an arrow) (magnification x 250). d: Virus genome-positive cells are
seeni in the lining of the kidney hilus both on7 the tubular and 1lymphoma side of mouse no. 9. Positive cells are also seen within the tubular lumina
(magnification x250). e: Adjacent section from (d) stained by immunoperoxidase methodfor the presence of viral antigen. No antigen-positive
cells were detected (magnification X250). Insert shows a positive control section from an infected lung at 5 days postinfection (magnification
x 500). f: Kidniey of mouise nlo. 22 shous vinrs genome-positive cells (indicated by an arrow) associated with lymphoma. Note the kidney paren-
chvnia has been largely replaced by abnormal Iyniphoid tissue (magnification X250). g: A magnified vieu' of virus genome-positive cellsfrom (f)
(niagnification X 1250). h: Vinrs geniome-positive cells in the endometrium of mouse no. 22 that developed high grade lymphoma (magnification
x 250). i: Adrenal cortex with virus genome-positive cells (indicated by arrow) associated with Iymphocyte infiltrations in mouse no. 22 (magnifi-
cation X 250). j: Liverfrom mouse no. 22 shouwing virus genome-positive Iymphoid cells within a lymphoma (magnification X 125). k: A magnified
tieun of vinrs genonme-positive lymphoid cells (indicated by an arrou in j) among genome-negative hepatocytes (magnification X 1250).
mas in spleen, mesenteric lymph node, liver, lung,
and kidney. Occasional positive cells of lymphoid cell
morphology could also be seen in the tissue paren-
chyma, suggesting perhaps the mode of spread. In
the spleen, positive cells were seen primarily in mar-
ginal zones or as scattered positive cells throughout
the tissue (Figure 4, a). In addition, scattered positive
cells were mainly associated with lymphomas ob-
served in liver, kidney, adrenal gland, and endome-
trium (Figure 4, h, i, and j).
In the kidney, some positive cells were also de-
tected within capillaries and tubular lumen or in the
wall (Figure 4, d). Positive cells could be detected in
peribronchiolar or perivascular masses of lympho-
mas in the lungs of mice that developed high grade
lymphomas (Figure 4, c). Animals that developed a
mild LPD also showed positive cells but these were
fewer in number compared with mice with high grade
lymphomas.
Again, negative immunoperoxidase staining for vi-
rus antigens in adjacent tissue sections using rabbit
polyclonal sera strongly suggested that the in situ-
positive cells are latently infected. None of the ani-
mals that developed abnormalities such as adeno-
carcinomas or atrial thrombosis showed either viral
DNA or viral antigens in these affected organs.
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Discussion
In a large study of mice chronically infected with MHV-
68, LPD was observed in 9% ranging from mild to high
grade lymphomas. In all cases virus genome-positive
cells were detected either in the lymphoma or asso-
ciated with the periphery, in some cases appearing in
very high numbers. The induction of lymphoid hyper-
plasia and lymphoid cell infiltration of the parenchyma
of organs such as the liver and kidney in MHV-68-
infected mice are also features observed in other
gammaherpesvirus infections.3'14
Why this disease process occurs in mice aged 9
months to 3 years is unclear. One obvious possibility
is that such animals may be more prone to immuno-
suppression than younger animals thus leading to a
breakdown in T cell control of latently infected B cells.
Certainly treatment of infected animals with CsA to
interfere with T cell function produced an increase in
the number of animals with lymphomas, arguing for a
role for T cells in controlling the emergence of tumors
in MHV-68-infected mice. This explanation is in agree-
ment in the events observed in EBV-driven LPD after
immunosuppression of virus-positive individuals. 1-5,16
In such cases the use of immunosuppressive therapy
resulted in a lymphoma incidence well above that in
the control population. In patients with posttransplant
lymphoproliferative disease (PTLPD) the histological
appearance varied from polymorphic (composed of
a mixture of cell types) to monomorphic proliferations
composed of large cells. The majority of these were
B lymphocytes, representing polyclonal B cell hyper-
plasia or clonal B cell neoplasia or lymphoma.17'18 In
MHV-68-infected mice a major site of virus latency is
the B lymphocyte and in vitro these cells transform
spontaneously to generate B cell lines (unpublished
observations). In all cases of high grade lymphoma
studied thus far, light chain restriction was seen in-
dicating a clonal origin of these B cells. The lympho-
mas were also composed of CD3-positive T cells,
suggesting that these might be responding to virus-
infected cells.
The heterogeneous scattered distribution of
MHV-68 DNA-positive cells in these lymphomas/
lymphoid hyperplasias is similar to the infectious
mononucleosis-like pattern described by Borisch-
Chappuis et al.19 for EBV-positive cells in patients
with PTLPD. In some cases of high grade lymphomas,
such as the spleen of mouse no. 9, a huge number of
genome-positive cells were located in the marginal
zone and others in the kidney and liver. Such infected
cells are not a characteristic feature of lymphomas in
EBV-infected patients and may reflect some differ-
ences between MHV-68 and EBV. Despite the strong
signal over individual infected cells, there was no evi-
dence of lytic viral antigens in adjacent sections of
lymphomas, indicating that these lymphoid cells
carry multiple copies of latent MHV-68 genomes. A
similar picture emerges in PTLPD where the pattern
of viral antigen expression is more like that of EBV-
transformed cells that lack lytic antigens.1'2'20
The failure to detect viral DNA in all cells of a par-
ticular lymphoma may be related to various factors.
One possibility is that low DNA copy numbers are not
detected by our in situ hybridization procedure. This
proved to be the case for a number of EBV-associated
lymphomas that were negative when probed for DNA
but positive for the viral transcripts EBERS.21-23 We
have still to identify genes and gene products asso-
ciated with latency that might allow us to identify virus-
positive lymphomas. Regardless of this, the restric-
tion of in situ-positive cells primarily to the areas of
lymphomas in nonlymphoid tissues of infected mice
strongly suggests an association between this virus
and the pathogenesis of LPD.
In conclusion, the association of MHV-68 in LPD of
mice further highlight the molecular and pathogenic
similarities to EBV and therefore identifies this virus as
a valuable model for the study of human disease
caused by EBV.
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